Elsa Solà, Santiago Sanchez‐Cabús, Ezequiel Rodriguez, Chiara Elia, Raquel Cela, Rebeca Moreira, Elisa Pose, Jordi Sánchez‐Delgado, Nuria Cañete, Manuel Morales‐Ruiz, Francisco Campos, Jaume Balust, Mónica Guevara, Juan Carlos García‐Valdecasas, Pere Ginès – 20 March 2017 – The alfapump system has been proposed as a new treatment for the management of refractory ascites. The system removes ascites from the peritoneal cavity to urinary bladder, producing a continuous low‐volume paracentesis.

Fu‐Ming Chang, Yen‐Po Wang, Hui‐Chu Lang, Chia‐Fen Tsai, Ming‐Chih Hou, Fa‐Yauh Lee, Ching‐Liang Lu – 20 March 2017 – Statin use decreases the risk of decompensation and mortality in patients with cirrhosis due to hepatitis C virus (HCV). Whether this beneficial effect can be extended to cirrhosis in the general population or cirrhosis due to other causes, such as hepatitis B virus (HBV) infection or alcohol, remains unknown. Statin use also decreases the risk of hepatocellular carcinoma (HCC) in patients with chronic HBV and HCV infection.

Duminda Suraweera, Sammy Saab – 20 March 2017

Søren Møller, Jens D. Hove – 20 March 2017

Duminda Suraweera, Sammy Saab – 20 March 2017

Alain Braillon – 20 March 2017

Reina Sasaki, Pradip B. Devhare, Robert Steele, Ranjit Ray, Ratna B. Ray – 20 March 2017 – Hepatitis C virus (HCV)–mediated chronic liver disease is a serious health problem around the world and often causes fibrosis/cirrhosis and hepatocellular carcinoma. The mechanism of liver disease progression during HCV infection is still unclear, although inflammation is believed to be an important player in disease pathogenesis. We previously reported that macrophages including Kupffer cells exposed to HCV induce proinflammatory cytokines.

Amy E.L. Stone, Michael J. Gale – 20 March 2017

Ângelo Zambam de Mattos, Suelen Aparecida da Silva Miozzo, Cristiane Valle Tovo, Angelo Alves de Mattos – 20 March 2017

Kyle S. McCommis, Jerry R. Colca, Brian N. Finck – 20 March 2017